CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Lossses)	Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2021		48,954,482
Balance at beginning of period at Dec. 31, 2021	$ 325,539	$ 759	$ 653,978	$ 92,111	$ 859	$ (422,168)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	12,074			12,074
Foreign currency translation	243				243
Stock-based compensation (in shares)		277,124
Stock-based compensation	2,277	$ 5	2,272
Stock repurchase (in shares)		(247,174)
Stock repurchase	(8,013)					(8,013)
Common stock dividends	(4,065)			(4,065)
Unrealized (loss) gain on derivative instruments	13,585				13,585
Stock option exercises (in shares)		48,208
Stock option exercises	613		613
Balance at end of period (in shares) at Mar. 31, 2022		49,032,640
Balance at end of period at Mar. 31, 2022	342,253	$ 764	656,863	100,120	14,687	(430,181)
Balance at beginning of period (in shares) at Dec. 31, 2022		47,675,796
Balance at beginning of period at Dec. 31, 2022	397,613	$ 766	665,941	188,241	(882)	(456,453)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	51,213			51,213
Foreign currency translation	564				564
Stock-based compensation (in shares)		480,463
Stock-based compensation	2,766	$ 8	2,758
Stock repurchase (in shares)		(540,875)
Stock repurchase	(23,566)					(23,566)
Common stock dividends	(4,055)			(4,055)
Unrealized (loss) gain on derivative instruments	(236)				(236)
Stock option exercises (in shares)		10,683
Stock option exercises	144		144
Balance at end of period (in shares) at Mar. 31, 2023		47,626,067
Balance at end of period at Mar. 31, 2023	$ 424,443	$ 774	$ 668,843	$ 235,399	$ (554)	$ (480,019)